Melissa A Fischer

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Venues

Cancer research communications

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer discovery

Vanderbilt University School of Medicine

Vanderbilt University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Vanderbilt University School of Medicine Aug 1o 2015

United States

Research Assistant Professor :: Internal Medicine

Education History

Vanderbilt University

United States

PHD :: Biochemistry

Publications

David C Florian, Natalie E Bennett, Mateusz Odziomek, Jessalyn J Baljon, Mohamed Wehbe, Alyssa R Merkel, Melissa A Fischer, Michael R Savona, Julie A Rhoades, Scott A Guelcher, John Tanner Wilson
Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction. Cancer research communications 3 (2) (2023)
David C Florian, Natalie E Bennett, Mateusz Odziomek, Jessalyn J Baljon, Mohamed Wehbe, Alyssa R Merkel, Melissa A Fischer, Michael R Savona, Julie A Rhoades, Scott A Guelcher, John Tanner Wilson
Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction. Cancer research communications 3 (2) (2023)
Haley E Ramsey, Dalton L Greenwood, Susu Zhang, Merrida Childress, Maria P Arrate, Agnieszka E Gorska, Londa Fuller, Yue Zhao, Kristy Stengel, Melissa A Fischer, Matthew C Stubbs, Phillip C C Liu, Kelli Boyd, Jeffrey C Rathmell, Scott W Hiebert, Michael R Savona
BET Inhibition Enhances the Antileukemic Activity of Low-dose Venetoclax in Acute Myeloid Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (2) (2020)
Haley E Ramsey, Melissa A Fischer, Taekyu Lee, Agnieszka E Gorska, Maria Pia Arrate, Londa Fuller, Kelli L Boyd, Stephen A Strickland, John Sensintaffar, Leah J Hogdal, Gregory D Ayers, Edward T Olejniczak, Stephen W Fesik, Michael R Savona
A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia. Cancer discovery 8 (12) (2018)

Melissa A Fischer.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Melissa A Fischer